Karyopharm Therapeutics GAAP EPS of -$3.82 misses by $0.30, revenue of $44.04M beats by $1.63M (NASDAQ:KPTI) - Reportify

Karyopharm Therapeutics GAAP EPS of -$3.82 misses by $0.30, revenue of $44.04M beats by $1.63M (NASDAQ:KPTI)

Karyopharm Therapeutics(US:KPTI) Seeking Alpha·2025-11-03 12:02

根据提供的文档内容，该文档不包含任何与公司或行业相关的实质性信息文档内容仅为一条技术性提示要求用户启用浏览器中的Javascript和cookies 并禁用广告拦截器以继续操作 [1]